Trials.ai Company

Trials.ai is leveraging artificial intelligence to root cause of failure in clinical trials: Trial Design – because patients don’t have time to wait. Trial sponsors spend $65B every year on clinical trials and 45% of those trials fail because they are poorly designed. These failures equate to billions of dollars in lost opportunity for trial sponsors every year - but more importantly, patients don't have time to wait for us to get it right. In the digital age, humans cannot physically read and digest every bit of information relevant to a given decision. In addition, almost every organization has what is called 'dark' or 'siloed' data – valuable data that is not being used, or that organizations don’t know they have at their disposal. It is estimated that as much as 90% of the data within a given organization is dark or siloed. As a result, pharmaceutical companies are making important decisions with incomplete information. ENTER TRIALS.AI - we are on a mission to get effective treatments to patients faster by using artificial intelligence to optimize clinical trial designs for speed and success. Unlike the current service models out there, we use smart technology to harness vast amounts of data that no human can process – then offer unique insights across therapeutic areas to trial sponsors. Using our codified clinical trials database, we are able to unlock information, derive insights and make recommendations to trial sponsors on how to best design & optimize their trial protocols. Based in San Diego, California, Trials.ai launched by Kim Walpole in 2016.
Technology: P4 Medicine
Industry: Artificial Intelligence, Clinical Trials, Machine Learning, Software
Headquarters: San Diego, California, United States
Founded Date: 2016-02-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 5
Estimated Revenue: Less than $1M
Last Funding Type: Convertible Note

Visit Website
info@trials.ai
https://twitter.com/trialsAI
Register and Claim Ownership